Long-term survival of a patient with metastatiс choroid plexus
carcinoma, de novo germline TP53 mutated, after craniospinal proton
irradiation
Abstract
Here we report a boy with disseminated choroid plexus carcinoma
diagnosed at an age of 2 years 9 months on the background of de novo
germline mutation in ТР53. The patient received 3 cycles of high-dose
methotrexate-based chemotherapy and 4 cycles of alternating
carboplatin/cyclophosphamide chemotherapy, followed by craniospinal
proton beam irradiation. To date, the patient lives with neither
progression of the disease nor other extracranial neoplasms for 6 years
from the diagnosis. This is the first successful experience of proton
irradiation therapy affording long-term survival in a child with
Li-Fraumeni syndrome-associated choroid plexus carcinoma.